Home › All Companies › BAX › Annual Report

BAXTER INTERNATIONAL INC (BAX) — Annual Report

AI-Powered SEC Filing Analysis

← All BAX filings
Latest Annual Report Filed: 2026-02-12

Key Insights

  • Baxter International Inc. (BAX) reported a 33.33% increase in operating income for the fiscal year 2025, indicating improved profitability.
  • The company's long-term debt and lease obligations, excluding current maturities, increased by a significant amount in 2025, potentially raising concerns about its financial leverage.
  • Baxter announced the divestiture of its Kidney Care and BioPharmaSolutions business segments, signaling a strategic shift in the company's focus.
Sentiment: Neutral Significance: 6/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-02-12. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for BAXTER INTERNATIONAL INC

Current Report Quarterly Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.